AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,652	3,347	6,587	7,284	24,377	10,132
Short-Term Investments	87,044	91,135	57,000	61,500	30,000	7,000
Cash & Short-Term Investments	91,696	94,482	63,587	68,784	54,377	17,132
Cash Growth	15.95%	48.59%	-7.56%	26.50%	217.40%	140.70%
Accounts Receivable	-	-	-	-	4,292	-
Other Receivables	1,867	1,634	595.17	255.83	147.07	25.71
Receivables	1,867	1,634	595.17	255.83	4,439	25.71
Prepaid Expenses	62.23	159.56	241.6	125.3	553.87	842.41
Other Current Assets	354.93	350.12	2,304	193.49	25.34	4.85
Total Current Assets	93,980	96,626	66,728	69,359	59,395	18,005
Property, Plant & Equipment	1,001	1,200	1,337	1,337	1,667	1,244
Long-Term Investments	999.95	999.95	11,000	0	0	-0
Other Intangible Assets	695.15	476.75	358.16	121.75	113.83	39.14
Other Long-Term Assets	347.65	296.28	279.23	246.39	200.58	121.15
Total Assets	97,025	99,599	79,702	71,065	61,376	19,410
Accrued Expenses	132.38	312.18	176.74	150.45	401.88	79.67
Short-Term Debt	1,609	2,740	5,472	-	-	-
Current Portion of Leases	216.8	264.11	247.12	219.84	204.68	122.43
Other Current Liabilities	4,466	5,166	15,849	1,417	3,439	19,714
Total Current Liabilities	6,425	8,482	21,746	1,787	4,045	19,916
Long-Term Leases	164.15	101.85	184.41	91.42	143.14	123.39
Other Long-Term Liabilities	28.57	26.78	24.28	24.45	22.55	12.43
Total Liabilities	6,617	8,611	21,954	1,903	4,211	20,052
Common Stock	22,800	22,436	21,574	10,561	9,180	697.51
Additional Paid-In Capital	143,416	137,481	126,746	135,659	116,365	1,715
Retained Earnings	-79,806	-72,350	-92,355	-78,226	-69,266	-16,553
Comprehensive Income & Other	3,997	3,422	1,782	1,168	887.2	363.87
Total Common Equity	90,407	90,988	57,747	69,162	57,165	-13,777
Shareholders' Equity	90,407	90,988	57,747	69,162	57,165	-641.55
Total Liabilities & Equity	97,025	99,599	79,702	71,065	61,376	19,410
Total Debt	1,990	3,106	5,904	311.26	347.82	245.82
Net Cash (Debt)	89,706	91,377	57,683	68,473	54,030	16,887
Net Cash Growth	24.15%	58.41%	-15.76%	26.73%	219.95%	145.74%
Net Cash Per Share	3985.44	4170.43	2702.58	3500.37	6479.89	4841.24
Filing Date Shares Outstanding	22.63	22.44	21.57	21.12	8.34	3.49
Total Common Shares Outstanding	22.63	22.44	21.57	21.12	8.34	3.49
Working Capital	87,556	88,144	44,982	67,572	55,350	-1,910
Book Value Per Share	3995.18	4055.51	2676.69	3274.38	6855.98	-3949.84
Tangible Book Value	89,712	90,511	57,389	69,040	57,052	-13,816
Tangible Book Value Per Share	3964.46	4034.26	2660.09	3268.62	6842.33	-3961.06
Machinery	2,535	2,493	2,176	2,072	1,908	1,333
Construction In Progress	-	-	-	-	150	150

Source: S&P Global Market Intelligence. Standard template. Financial Sources.